|
Lupus Erythematosus, Systemic
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus.
|
26502338 |
2015 |
|
Neoplasms
|
0.030 |
AlteredExpression
|
group |
BEFREE |
MIR210HG high-expression was correlated advanced clinical stage, big tumor size, present vascular invasion and unfavorable histological differentiation.
|
30841443 |
2019 |
|
Neoplasms
|
0.030 |
AlteredExpression
|
group |
BEFREE |
MIR210HG expression was correlated to tumor stage and lymph node metastasis of NSCLC patients.
|
31190878 |
2019 |
|
Tumor Cell Invasion
|
0.030 |
Biomarker
|
phenotype |
BEFREE |
Knockdown of MiR210HG suppressed IBC cell invasion and metastasis both in <i>vitro</i> and in <i>vivo</i>.
|
31399552 |
2019 |
|
Tumor Cell Invasion
|
0.030 |
Biomarker
|
phenotype |
BEFREE |
Regulatory effects of MIR210HG on proliferation, migration, and invasion of NSCLC cells were detected by CCK-8, colony formation, and transwell assay, respectively.
|
31190878 |
2019 |
|
Tumor Cell Invasion
|
0.030 |
Biomarker
|
phenotype |
BEFREE |
The in vitro study showed that silencing of MIR210HG depressed HCC cell proliferation, migration and invasion.
|
30841443 |
2019 |
|
Neoplasms
|
0.030 |
Biomarker
|
group |
BEFREE |
In vivo, miR210HG silencing decreased the tumor growth. miR-503 was verified to be the target miRNA of miR210HG using bioinformatics online program and luciferase assay.
|
28972855 |
2017 |
|
Neoplasm Metastasis
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
Knockdown of MiR210HG suppressed IBC cell invasion and metastasis both in <i>vitro</i> and in <i>vivo</i>.
|
31399552 |
2019 |
|
Osteosarcoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
MIR210HG is a novel long noncoding RNA (lncRNA) and has been found to be overexpresed in osteosarcoma and glioma.
|
30841443 |
2019 |
|
Osteosarcoma of bone
|
0.020 |
Biomarker
|
disease |
BEFREE |
MIR210HG is a novel long noncoding RNA (lncRNA) and has been found to be overexpresed in osteosarcoma and glioma.
|
30841443 |
2019 |
|
Childhood Osteosarcoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
MIR210HG is a novel long noncoding RNA (lncRNA) and has been found to be overexpresed in osteosarcoma and glioma.
|
30841443 |
2019 |
|
Neoplasm Metastasis
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
Long Noncoding RNA miR210HG Sponges miR-503 to Facilitate Osteosarcoma Cell Invasion and Metastasis.
|
28972855 |
2017 |
|
Osteosarcoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
In conclusion, our study indicates that miR210HG sponges miR-503 to facilitate osteosarcoma cell invasion and metastasis, revealing the oncogenic role of miR210HG on osteosarcoma cells.
|
28972855 |
2017 |
|
Osteosarcoma of bone
|
0.020 |
Biomarker
|
disease |
BEFREE |
In conclusion, our study indicates that miR210HG sponges miR-503 to facilitate osteosarcoma cell invasion and metastasis, revealing the oncogenic role of miR210HG on osteosarcoma cells.
|
28972855 |
2017 |
|
Childhood Osteosarcoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
In conclusion, our study indicates that miR210HG sponges miR-503 to facilitate osteosarcoma cell invasion and metastasis, revealing the oncogenic role of miR210HG on osteosarcoma cells.
|
28972855 |
2017 |
|
Malignant tumor of colon
|
0.010 |
Biomarker
|
disease |
BEFREE |
Further predictions suggested that MIR210HG may affect colon cancer via transcription and post-transcriptional processing.
|
31423171 |
2019 |
|
Non-Small Cell Lung Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
<b>Results:</b> MIR210HG was highly expressed in NSCLC tissues not only in GSE30219 dataset but also in our collected NSCLC tissues.
|
31190878 |
2019 |
|
Glioma
|
0.010 |
Biomarker
|
disease |
BEFREE |
MIR210HG is a novel long noncoding RNA (lncRNA) and has been found to be overexpresed in osteosarcoma and glioma.
|
30841443 |
2019 |
|
Inflammatory Breast Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Knockdown of MiR210HG suppressed IBC cell invasion and metastasis both in <i>vitro</i> and in <i>vivo</i>.
|
31399552 |
2019 |
|
Carcinogenesis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
<b>Conclusion:</b> MIR210HG can promote the tumorigenesis of NSCLC by inhibiting the expression of CACNA2D2.
|
31190878 |
2019 |
|
Secondary malignant neoplasm of lymph node
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
MIR210HG expression was correlated to tumor stage and lymph node metastasis of NSCLC patients.
|
31190878 |
2019 |
|
Colon Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Further predictions suggested that MIR210HG may affect colon cancer via transcription and post-transcriptional processing.
|
31423171 |
2019 |
|
Invasive carcinoma of breast
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The long noncoding RNA MIR210HG promotes tumor metastasis by acting as a ceRNA of miR-1226-3p to regulate mucin-1c expression in invasive breast cancer.
|
31399552 |
2019 |
|
Adenocarcinoma of large intestine
|
0.010 |
Biomarker
|
disease |
BEFREE |
In contrast, MIR210HG participated in the progression of colorectal adenocarcinoma by regulating hypoxia.
|
30362555 |
2019 |
|
Liver carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
The in vitro study showed that silencing of MIR210HG depressed HCC cell proliferation, migration and invasion.
|
30841443 |
2019 |